Abstract: A stent shaped as a three-dimensional body which is formed by interlaced threads (1) arranged in multistart turns of a helical line. The threads (1) are arranged in at least two groups (2 and 3) of the helical turns featuring opposite senses of helix. The stent ends are established by sections (5) where the turns of one helical line merge into those of the other helical line, said sections appearing as a single length of the thread (1).

Abstract: The invention is directed to an expandable stent for implantation in a body lumen, such as an artery, and a method for making it from a single length of tubing. The stent consists of a plurality of radially expandable cylindrical elements generally aligned on a common axis and interconnected by one or more interconnective elements. The individual radially expandable cylindrical elements consist of ribbon-like material disposed in an undulating pattern. Portions of the expanded stent project outwardly into engagement with the vessel wall to more securely attach the stent.

Abstract: A stent for use in the treatment of stenosis of the ostium of tubular organs, more particularly, blood vessels comprising a multiplicity of flanges located at an end of a generally tubular stent body. The flanges permit the accurate positioning of the stent within the vessel, while presenting dislodgement of the stent.

Abstract: A conduit is provided to provide a bypass around a blockage in the coronary artery. The conduit is adapted to be positioned in the myocardium or heart wall to provide a passage for blood to flow between a chamber of the heart such as the left ventricle and the coronary artery, distal to the blockage. The stent is self-expanding or uses a balloon to expand the stent in the heart wall. Various attachment means are provided to anchor the stent and prevent its migration.

Abstract: This invention relates to implants useful as stents for opening or strengthening biological conduits, or as grafts or conduits for replacing or connecting portions of biological tissues having a lumen. Accordingly, the implants of this invention may be applied in portions of the peripheral and coronary vascular system, biliary, urinary, esophageal, digestive, ocular, tracheal, bronchial, reproductive, and neural systems. The implant comprises a segment of bone having a lumen through at least a part thereof, and wherein at least a portion of the implant is demineralized so as to be pliable.

Abstract: A stent-graft having an exo-skeleton attached to a tubular graft, the tubular graft having a peripheral wall defining a lumen therein extending between first and second ends. The exo-skeleton may assume contracted and enlarged conditions, and includes one or more serpentine elements, each extending both peripherally and axially along at least a portion of the peripheral wall. Coiled-sheet stents are provided on the ends of the tubular graft for anchoring the ends within a body passage. Each serpentine element is a zigzag structure extending peripherally about the peripheral wall, with a plurality of serpentine elements distributed axially along the peripheral wall. The serpentine elements are individually attached to the peripheral wall and/or connector elements may extend between adjacent serpentine elements. Alternatively, each serpentine element may define a generally sinusoidal shape extending axially along the peripheral wall.

Abstract: A prosthesis system for partial or total articular surface replacement includes a tail module having one or more grooves at one end thereof and a first ball joint component at an opposite end thereof; an articular module, a portion of which has an anatomic shape of a distal radial articular surface, another portion of which is provided with a second ball joint component; and a collar module interposed between the tail module and the articular module, and comprising a pair of sockets adapted to receive the first and second ball joint components of the tail module and articular module

Abstract: Delivery of rapamycin locally, particularly from an intravascular stent, directly from micropores in the stent body or mixed or bound to a polymer coating applied on stent, to inhibit neointimal tissue proliferation and thereby prevent restenosis. This invention also facilitates the performance of the stent in inhibiting restenosis.

Abstract: The invention is directed to an expandable stent for implantation in a body lumen, such as an artery. The stent consists of an elongated stent body formed with a central section positioned between a proximal end section and a distal end section, each having different radial expansion characteristics. The end sections of the stent are configured to have greater resistance to radial expansion than the corresponding central section such that, when deployed with a balloon catheter device, the central section of the stent expands to an enlarged final diameter to contact the interior walls of the body lumen before or simultaneously with the end sections as fully expanded. During stent deployment, radially outwardly acting forces applied to the stent deform the U-shaped structures in the circumferential direction thereby producing radial expansion of respective cylindrical elements.

Abstract: A front end wire ring 101, and a rear end wire ring 102 are arranged facing each other, and a tubular cover 7 connects the front and rear end wire rings 101 and 102, and an intermediate wire ring 12 is arranged between the front and rear end wire rings 101 and 102, wherein each of the wire rings 101, 102 and 12 is given flexibly foldable elasticity. The front and rear end wire rings 101 and 102 and at least the intermediate wire rings 12 arranged adjacent to the front and rear end wire rings 101 and 102 is connected with the cover 7 through a film member 30 so that the wire rings 101, 102 and 12 can make a back and forth movement relative to the cover 7 within a certain range and that an annular gap formed between the wire rings 101, 102 and 12 and the cover 7 is liquid-tightly sealed.

Abstract: Apparatus and method are disclosed for maintaining the proper positioning of an implant (310, 504) within a prepared bone cavity (312) during cement injection and curing. First stabilization means (340, 480), implantable within the bone cavity, minimize lateral movement of the implant distal end, while second stabilization means (330, 334, 406, 404), physically separate from the first stabilization means (340, 480), minimize both the lateral movement of the implant proximal end and the rotational movement of the implant overall. In the preferred embodiment, the second stabilization means (330, 334) includes an aperture cap (334) removable securable to the end of a prepared bone. This cap (334), preferably further includes first and second ports (322, 336) associated, respectively, with cement injection and cement over-pressurization.

Abstract: The invention provides an article of manufacture comprising a substantially non-immunogenic soft tissue xenograft for implantation into humans. The invention further provides methods for preparing a soft tissue xenograft by removing at least a portion of a soft tissue from a non-human animal to provide a xenograft; washing the xenograft in saline and alcohol; subjecting the xenograft to cellular disruption treatment; and digesting the xenograft with a proteoglycan-depleting factor and/or glycosidase and optionally following with a capping treatment. The invention also provides an article of manufacture produced by the above-identified method of the invention. The invention further provides a soft tissue xenograft for implantation into a human including a portion of a soft tissue from a non-human animal, wherein the portion has extracellular components and substantially only dead cells. The extracellular components have reduced proteoglycan molecules.

Abstract: In accordance with the present invention, there is provided a stent for implantation into a vessel of a patient. The stent has at least two plastically deformable and expandable tubular graft members for expansion within a vessel. Each of the graft member has a first end, a second end, a wall section disposed therebetween and a lumen extending therethrough. The stent further includes at least one articulation connecting the first end of one of the graft members with the second end of the other graft member. Wherein the articulation is made from a superelastic material.

Abstract: A stent is a device that is adapted to be implanted into narrowed portions of hollow vessels of a body. The stent (1) comprises a stent body (2) that has at least two different wall thicknesses (WE, WH). The different wall thicknesses result in different flexibility characteristics of the stent in the longitudinal direction. Thus the stent according to the invention prevents irritations of the wall of the vessel in the area of the implanted stent, whereby the risk of restenosis in said area can be reduced considerably.

Abstract: Systems and methods are described for implants with composite coatings to promote tissue in-growth and/or on-growth. An implant includes: a substrate; a structured surface formed on at least a portion of the substrate; and a biocompatible coating deposited on at least a fraction of the structured surface. The systems and methods provide advantages in that the implant has good biocompatibility while the biocompatible coating has good strength.

Abstract: A novel endovascular approach useful in the treatment of aneurysms, particularly saccular aneurysms. The present endovascular prosthesis comprises a leaf portion capable of being urged against and blocking the opening of the aneurysm thereby leading to obliteration of the aneurysm. The leaf portion is attached to, and independently moveable with respect to, a body comprising at least one expandable portion. Thus, the body serves the general purpose of fixing the endovascular prosthesis in place at a target body passageway in the vicinity at which the aneurysm is located and the leaf portion serves the purpose of blocking the aneurysmal opening thereby leading to obliteration of the aneurysm. A method of delivering and implanting the endovascular prosthesis is also described.

Abstract: A radially expandable stent comprising a plurality of spaced band-like elements and intersecting links is disclosed. The band-like elements have a generally serpentine configuration to provide continuous waves of generally sinusoidal character to each band-like element. The waves are characterized by a plurality of peaks and troughs taking a generally longitudinal direction along the cylinder such that the waves in the band-like elements open as the stent is expanded from a first diameter to a second diameter. The intersecting links are substantially U-shaped and terminate in first and second shanks. The first shank of a link emanates from a region between a peak and trough on a band-like element and the second shank of the link emanates from a region between a peak and trough on an adjacent band-like element.

Abstract: A stent comprising varying porosity's for use in vessels with bifurcations or side branches. The stent allows for scaffolding of the stenotic area but still allows for flow into the side branches. A distal protection system is also described.

Abstract: An allogenic intervertebral implant for fusing vertebrae is disclosed. The implant is a piece of allogenic bone conforming in size and shape with a portion of an end plate of a vertebra. The implant has a wedge-shaped profile to restore disc height and the natural curvature of the spine. The top and bottom surfaces of the implant have a plurality of teeth to resist expulsion and provide initial stability. The implant according to the present invention provides initial stability need for fusion without stress shielding.

Abstract: A multi-section stent includes a connecting structure that allows the stent sections to move and flex relative to one another. For deployment and positioning, the connecting structure connects the multiple stent sections and holds the stent sections substantially stationary relative to one another. Following deployment, the connecting structure allows the multiple stent sections to move relative to one another. Movable stent sections enable flexure of the stent upon deployment within a body lumen. This flexing structure allows better conformance of the stent to the shape of the body lumen, and exerts less overall pressure against the lumen wall, reducing the potential for trauma. Upon deployment, the multiple stent sections may be completely detached from one another. Alternatively, the stent sections may remain partially connected in a manner that allows substantial independent movement.